Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA and Tailored Radiotherapy in Head and Neck Squamous Cell Carcinoma
NCT06706401Phase 3Recruiting
- Sponsor
- Centre Léon Bérard
- Start
- Feb 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tretinoin in head and neck squamous cell carcinoma (HNSCC), sponsored by Centre Léon Bérard. Started Feb 2025; status: recruiting.
02
Drugs
tretinoin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT06706401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06706401.